Soleus Capital Management’s Mereo BioPharma MREO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.63M | Sell |
599,711
-87,242
| -13% | -$236K | 0.11% | 77 |
|
|
2025
Q1 | $1.55M | Sell |
686,953
-100,000
| -13% | -$225K | 0.11% | 66 |
|
|
2024
Q4 | $2.75M | Sell |
786,953
-60,000
| -7% | -$210K | 0.17% | 63 |
|
|
2024
Q3 | $3.48M | Sell |
846,953
-400,000
| -32% | -$1.64M | 0.27% | 68 |
|
|
2024
Q2 | $4.49M | Sell |
1,246,953
-1,370,000
| -52% | -$4.93M | 0.4% | 63 |
|
|
2024
Q1 | $8.64M | Sell |
2,616,953
-7,160,466
| -73% | -$23.6M | 0.64% | 47 |
|
|
2023
Q4 | $22.6M | Buy |
9,777,419
+100,000
| +1% | +$231K | 2.51% | 16 |
|
|
2023
Q3 | $12.5M | Buy |
+9,677,419
| New | +$12.5M | 1.15% | 30 |
|